DCGI granted permission to Biological E Limited to conduct phase 2/3 clinical trials of its 'Made in India' COVID-19 vaccine on children aged between 5 and 18 years with certain conditions
from Latest News https://ift.tt/3zx1Lu9
Wednesday, 1 September 2021
DGCI gives nod for phase 2/3 trials of Biological E's Covid vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment